Pseudarthrosis SALVAT

Ensayo Clinico HC-SVT-1001 ITRT-Hospital La Paz

The pharmaceutical company SALVAT is sponsoring this multicentre clinical trial conducted by ITRT at Centro Médico Teknon in Barcelona and by the Department of Orthopaedics and Traumatology of Hospital Universitario La Paz of Madrid.

The purpose of the trial is to confirm the usefulness and safety, as well as the efficacy, of an innovative advanced therapy medicinal product known as HC-SVT-1001, comprising adipose tissue mesenchymal stem cells from the patients themselves which, once selected and cultured by HISTOCELL of Bilbao, are inserted into a tricalcium phosphate biomaterial specially designed for stem cells.

The product is provided to surgeons to prevent further cell handling and cell loss.

The clinical trial protocol has been approved by the respective ethics committees of the participating hospitals and by the Spanish Agency of Medicines and Medical Devices.

The satisfactory results of the preliminary ovine clinical trials at the AO research centre located in Davos have led to high hopes for this advanced therapy.

Patient enrolment for this study is open.
Treatment is free of charge.
Please phone 932 906 042 for more information.

Link to record at

Clinical Trial Technical Datasheet

Última actualización: 25/10/2019